All Releases
 |
Cumberland Pharmaceuticals to Present at Lazard Healthcare Conference in New York on November 17, 2009
Nov 2, 2009
|
8.3 KB |
|
| |
NASHVILLE, Tenn., Nov 02, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that Chief Executive Officer A.J. Kazimi and Chief Commercial Officer Martin E. Cearnal will present an upda...
|
|
Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
Oct 29, 2009
|
13.5 KB |
|
| |
Nashville, Tenn., Oct 29, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX)and Phebra Pty Ltd., an Australian-based specialty pharmaceutical company, today announced they have entered into an exclusive partnership for the commercialization of Caldolor(R) (ibuprofen) Injection in Australia and New...
|
|
Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
Oct 27, 2009
|
8.5 KB |
|
| |
NASHVILLE, Tenn., Oct 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it will report third quarter 2009 financial results before the market opens on Tuesday, November 10, 2009. A conference call and live Internet webcast will be held on Tuesday, November 10, 2009 at 10...
|
|
Newly Published Clinical Data Shows Caldolor(R) (Ibuprofen) Injection Reduces Opioid Use While Improving Pain Relief in Post-Operative Patients
Oct 19, 2009
|
13.8 KB |
|
| |
NASHVILLE, Tenn., Oct 19, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study con...
|
|
Cumberland Pharmaceuticals Announces Presentation of Caldolor Data at American Academy of Pain Management Meeting
Oct 5, 2009
|
9.8 KB |
|
| |
NASHVILLE, Tenn., Oct 05, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that data from two key clinical trials for Caldolor(R), an intravenous formulation of ibuprofen approved for treatment of pain and fever in adults, will be presented at the American Academy of Pain Managem...
|
|
Cumberland Pharmaceuticals Inc. (CPIX) Chief Executive Officer A.J. Kazimi to Ring the NASDAQ Stock Market Closing Bell
Sep 18, 2009
|
12.2 KB |
|
| |
ADVISORY, Sep 18, 2009 (GlobeNewswire via COMTEX News Network) --
What:
Cumberland Pharmaceuticals Inc. (CPIX) will visit the NASDAQ
MarketSite in New York City's Times Square to celebrate the company's
recent IPO. Cumberland priced its IPO on August 10, 2009, representing
the first biopharmaceutical IPO in the U.S. in nearly two years...
|
|
Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
Sep 9, 2009
|
16.3 KB |
|
| |
NASHVILLE, Tenn., Sept 09, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it has successfully implemented the U.S. launch of Caldolor((R)), an intravenous formulation of ibuprofen, designed primarily for use in the hospital setting. Caldolor is the first and only injectable...
|
|
Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21, 2009
Aug 31, 2009
|
8.4 KB |
|
| |
NASHVILLE, Tenn., Aug 31, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that Chief Executive Officer A.J. Kazimi will present at the UBS Global Life Sciences Conference in New York ...
|
|
Cumberland Pharmaceuticals Reports Second Quarter 2009 Financial Results
Aug 27, 2009
|
24.0 KB |
|
| |
NASHVILLE, Tenn., Aug 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on the hospital acute care and gastroenterology markets, today announced second quarter 2009 financial results.
"Our second quarter and the weeks since have encompassed two of t...
|
|
Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009
Aug 24, 2009
|
8.3 KB |
|
| |
NASHVILLE, Tenn., Aug 24, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that it will report second quarter 2009 financial results before the market opens on Thursday, August 27, 2009. A conference call and live Internet webcast will be held on Thursday, August 27, 2009 at 10:0...
|
|
Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock
Aug 10, 2009
|
9.5 KB |
|
| |
NASHVILLE, Tenn. (August 10, 2009) - Cumberland Pharmaceuticals Inc. announced today the pricing of its initial public offering of 5,000,000 shares of the Company's common stock at a price to the public of $17.00 per share, raising $85.0 million in gross proceeds before deducting underwriting discounts and commissions as well as offering ...
|
| |
Cumberland Pharmaceuticals Announces FDA Approval of Caldolor™
Jun 11, 2009
|
26.8 KB |
|
| |
Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote®
May 18, 2009
|
43.8 KB |
|
| |
Cumberland Pharmaceuticals Appoints Lee Product Director
Jan 13, 2009
|
35.5 KB |
|
| |
Cumberland Pharmaceuticals Reports FDA Approval for Updated Labeling of Acetadote®
Dec 18, 2008
|
47.5 KB |
|
| |
Cumberland Pharmaceuticals Taps Industry Veteran for Key Executive Position
Sep 3, 2008
|
33.0 KB |
|
| |
Kristalose® Offers Prescription Alternative to Miralax® and Other Peg 3350 Products
Feb 26, 2008
|
40.6 KB |
|
| |
Cumberland Pharmaceuticals Announces Appointments
Dec 18, 2007
|
35.7 KB |
|
| |
Cumberland Pharmaceuticals Announces Senior Management Promotions
Nov 12, 2007
|
49.8 KB |
|
| |
Cumberland Pharmaceuticals Inc. Announces Estimated Price Range For Initial Public Offering
Jul 23, 2007
|
28.0 KB |
|
|
|
